Feasibility of a brief intervention for medication-overuse headache in primary care - A pilot study

被引：4
作者：
Kristoffersen E.S. [1 ,2 ]
Straand J. [1 ]
Russell M.B. [3 ,4 ]
Lundqvist C. [2 ,4 ,5 ]
机构：
[1] Department of General Practice, Institute of Health and Society, University of Oslo, Blindern, 0318 Oslo
[2] Health Service Research Centre, Research Centre, Akershus University Hospital, 1478 Lørenskog
[3] Head and Neck Research Group, Research Centre, Akershus University Hospital, 1478 Lørenskog
[4] Institute of Clinical Medicine, Akershus University Hospital, University of Oslo, Nordbyhagen
[5] Department of Neurology, Akershus University Hospital, Nordbyhagen
来源：
BMC Research Notes | / 7卷 / 1期
关键词：
Brief intervention; Chronic headache; Feasibility study; General practice; Medication-overuse headache; Migraine; Pilot study; Severity of dependence scale;
D O I：
10.1186/1756-0500-7-165
中图分类号：
学科分类号：
摘要：
Background: Medication-overuse headache (MOH) is a common problem in primary care. Brief intervention (BI) has successfully been used for detoxification from overuse of alcohol and drugs. The aim of this pilot study was to develop and test methodology, acceptability and logistics for a BI for MOH in primary care. Findings. Observational feasibility study of an intervention in a Norwegian general practice population.Six general practitioners (GPs) were recruited. A screening questionnaire for MOH was sent to all 18-50 year old patients on these GPs' list. GPs were taught BI, which was applied to MOH patients as follows: Severity of dependence scale (SDS) scores were collected and individual feedback was given of the relationship between the SDS, medication overuse and headache. Finally, advice to reduce medication was given. Patients were invited to a headache interview three months after the BI. Main outcomes were feedback from GPs/patients about the feasibility and logistics of the study design, screening/recruitment process, BI and headache interviews. Efficacy and patient-related outcomes were not focused. The patients reported a high degree of acceptability of the methodology. The GPs reported the BI to be feasible to implement within a busy practice and to represent a new and improved instrument for communication with MOH patients. The BI requires further testing in a randomised controlled trial (RCT) in order to provide evidence of efficacy. Conclusion: This feasibility study will be used to improve the BI for MOH and the design of a cluster-RCT. Trial registration. ClinicalTrials.gov: NCT01078012 (Initially registered as controlled efficacy trial but changed to observational study). © 2014 Kristoffersen et al.; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 49 条
  • [1] Latinovic R., Gulliford M., Ridsdale L., Headache and migraine in primary care: Consultation, prescription, and referral rates in a large population, J Neurol Neurosurg Psychiatry, 77, pp. 385-387, (2006)
  • [2] Kristoffersen E.S., Grande R.B., Aaseth K., Lundqvist C., Russell M.B., Management of primary chronic headache in the general population: The Akershus study of chronic headache, J Headache Pain, 13, pp. 113-120, (2012)
  • [3] Kristoffersen E.S., Lundqvist C., Aaseth K., Grande R.B., Russell M.B., Management of secondary chronic headache in the general population: The Akershus study of chronic headache, J Headache Pain, 14, (2013)
  • [4] Jonsson P., Hedenrud T., Linde M., Epidemiology of medication overuse headache in the general Swedish population, Cephalalgia, 31, pp. 1015-1022, (2011)
  • [5] Castillo J., Munoz P., Guitera V., Pascual J., Kaplan Award 1998. Epidemiology of chronic daily headache in the general population, Headache, 39, pp. 190-196, (1998)
  • [6] Aaseth K., Grande R.B., Kvaerner K.J., Gulbrandsen P., Lundqvist C., Russell M.B., Prevalence of secondary chronic headaches in a population-based sample of 30-44-year-old persons. The Akershus study of chronic headache, Cephalalgia, 28, pp. 705-713, (2008)
  • [7] Lanteri-Minet M., Auray J.P., El Hasnaoui A., Dartigues J.F., Duru G., Henry P., Lucas C., Pradalier A., Chazot G., Gaudin A.F., Prevalence and description of chronic daily headache in the general population in France, Pain, 102, pp. 143-149, (2003)
  • [8] Colas R., Munoz P., Temprano R., Gomez C., Pascual J., Chronic daily headache with analgesic overuse: Epidemiology and impact on quality of life, Neurology, 62, pp. 1338-1342, (2004)
  • [9] Diener H.C., Limmroth V., Medication-overuse headache: A worldwide problem, Lancet Neurol, 3, pp. 475-483, (2004)
  • [10] Evers S., Marziniak M., Clinical features, pathophysiology, and treatment of medication-overuse headache, Lancet Neurol, 9, pp. 391-401, (2010)
12345